IMMPIMMUTEP Ltd同业对比
IMMUTEP Ltd 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMP本股 | $4.4B#3 | — | — | — | — | — | — | — | — | — | -91.8%#6 | — |
| GSK | $210.3B#1 | — | — | — | — | — | — | — | — | — | 5.2%#3 | — |
| HCM | $11.4B#2 | 25.2x#2 | 9.2x#1 | 20.8x#2 | -13.0%#2 | 1111.0%#2 | -7.1%#3 | 36.9%#1 | 0.0%#2 | — | -15.1%#4 | — |
| HELP | $194M#7 | — | — | — | — | — | — | — | — | — | 33.5%#1 | — |
| HMDCF | — | — | — | — | -13.0%#2 | 1111.0%#2 | -7.1%#3 | 36.9%#1 | 0.0%#2 | — | — | — |
| HSTC | — | — | — | — | — | -0.8%#6 | — | -11.8%#3 | — | — | — | — |
| HYFT | $50M#9 | — | — | — | — | — | — | — | — | — | — | — |
| IFRX | $117M#8 | — | — | — | — | — | — | — | — | — | — | — |
| IMRN | $281M#5 | — | — | — | — | — | — | — | — | — | — | — |
| IMRX | — | — | — | — | -100.0%#5 | 8.2%#4 | — | -33.2%#5 | — | — | -43.8%#5 | — |
| INBP | — | — | — | — | -19.3%#4 | -451.7%#7 | -6.2%#2 | -16.1%#4 | -20.5%#4 | 4#2 | — | — |
| INCR | $275M#6 | — | — | — | — | — | — | — | — | — | — | — |
| INDV | $4.3B#4 | 10.2x#1 | — | 3.5x#1 | 4.3%#1 | 2900.0%#1 | 21.1%#1 | — | 187.2%#1 | 5#1 | 23.5%#2 | — |
| INTI | — | — | — | — | — | 1.2%#5 | — | — | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-04。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议